Skip to main content
Clinical Trials/NCT01252615
NCT01252615
Completed
Phase 2

Patient and Intimate Partner Intervention to Improve Outcomes After an ICD

University of Washington1 site in 1 country301 target enrollmentJuly 2009

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Implantable Cardioverter Defibrillator (ICD)
Sponsor
University of Washington
Enrollment
301
Locations
1
Primary Endpoint
Physical functioning
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The goal of this study is to compare a patient only to a patient+partner intervention on recovery outcomes of patients and partners after Implantable Cardioverter Defibrillator (ICD) implantation.

Detailed Description

The goal of this randomized trial is to test a patient+partner intervention against the patient only intervention on recovery outcomes of patients and partners after ICD implantation. By interventing with both ICD patients and their partners, we expect to further improve outcomes of patients and aid in recovery of partners. Over a five year period we will test the effects of a 12 week patient+partner intervention against a patient only intervention in the first year subsequent to ICD implantation, using a 2 group (N=150/group) randomized clinical trial design. Relevant data will be collected on ICD patients and intimate partners at hospital discharge, 1, 3, 6, 12 months post-ICD implantation. The four major outcomes are: physical functioning, psychological adjustment, health care utilization, and relationship impact. The primary analysis of treatment effect is the change in outcome variables from baseline to 3 months for the patient and partner. Secondarily, exploring long term effects of the intervention, theoretical elements, and the intervention effects by ICD implant reason will be determined.

Registry
clinicaltrials.gov
Start Date
July 2009
End Date
October 2015
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Cynthia M. Dougherty

Professor, Biobehavioral Nursing and Health Systems

University of Washington

Eligibility Criteria

Inclusion Criteria

  • first ICD implantation due to either primary or secondary prevention of SCA
  • intimate partner (spouse, lover, or life partner) living at the same residence and willing to participate
  • able to read, speak, and write English
  • access to telephone for 1 year after ICD implantation

Exclusion Criteria

  • clinical co-morbidities that severely impair cognitive and physical functioning at telephone screening
  • Short BLESSED score \> 6
  • age less than 21 years
  • AUDIT-C score \> 4 for alcohol use
  • ASSIST 2.0 score \> 4 for daily non-medical use of opiates or hallucinogens,

Outcomes

Primary Outcomes

Physical functioning

Time Frame: 3 months

symptoms, health related quality of life, steps/day

Secondary Outcomes

  • psychological adjustment(3 months)

Study Sites (1)

Loading locations...

Similar Trials